In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.
In the published article, there was an error in the Ethics statement. The IRB number was incorrectly displayed as “IRB no. N20210313”. The correct IRB number is “IRB no. N202103013”. The correct Ethics statement appears below.
Statements
Ethics statement
The study protocol was approved by the Joint Institutional Review Board of Taipei Medical University (IRB no. N202103013). The patients/participants provided their written informed consent to participate in this study.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
heparin-binding EGF-like growth factor (HBEGF), bioinformatics, biomarker, immune infiltration, macrophage chemotaxis, non-small cell lung cancer
Citation
Van Hiep N, Sun W-L, Feng P-H, Lin C-W, Chen K-Y, Luo C-S, Dung LN, Van Quyet H, Wu S-M and Lee K-Y (2022) Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma. Front. Oncol. 12:1106553. doi: 10.3389/fonc.2022.1106553
Received
23 November 2022
Accepted
29 November 2022
Published
13 December 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Van Hiep, Sun, Feng, Lin, Chen, Luo, Dung, Van Quyet, Wu and Lee.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kang-Yun Lee, leekangyun@tmu.edu.tw; Sheng-Ming Wu, chitosan@tmu.edu.tw
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.